Feasibility and Ergonomic Impact of A Virtual Reality Headset in Endoscopic Procedures
1 other identifier
interventional
140
1 country
1
Brief Summary
The purpose of this study is to assess the feasibility of using a virtual reality headset (VRH) during endoscopy and its impact on the endoscopist ergonomics. We will use the Apple Vision Pro during approximately 140 endoscopic procedures during which ergonomics will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2026
CompletedFirst Submitted
Initial submission to the registry
March 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
March 25, 2026
March 1, 2026
6 months
March 11, 2026
March 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Risk Reduction of endoscopy related musculoskeletal injury by VRH as assessed by rapid entire body assessment (REBA) score.
The REBA score is an ergonomic assessment tool used to identify potential risks of musculoskeletal disorders in the workplace by evaluating posture and movements. The score ranges from 0-15 with 0 being the lowest risk and 15 being the highest risk. A two point decrease pre-intervention will be considered significant.
From the start until the end of an endoscopic procedure.
Secondary Outcomes (3)
Endoscopist experience with VRH assess via subjective survey scored on a 5-point Likert scale.
From the start until the end of an endoscopic procedure.
Risk reduction of endoscopic related musculoskeletal injury in specific subgroups (colonoscopy, EUS, ERCP) by VRH as assessed by rapid entire body assessment (REBA) score.
From the start until the end of an endoscopic procedure.
risk reduction of endoscopy related musculoskeletal injury due to pre-procedural checklist as assessed by rapid entire body assessment (REBA) score.
From the start until the end of an endoscopic procedure.
Study Arms (2)
NonVRH
ACTIVE COMPARATOREndoscopic procedure without virtual reality headset (VRH)
VRH
ACTIVE COMPARATOREndoscopic procedure completed with virtual reality headset (VRH)
Interventions
Eligibility Criteria
You may qualify if:
- Endoscopist: endoscopist at Cleveland Clinic Weston who consent to participate in the study and are performing either colonoscopy, EUS, or ERCP.
- Patient: patient undergoing colonoscopy, EUS, or ERCP
You may not qualify if:
- Exclude the following procedures: Device-assisted colonoscopy (e.g.- double balloon, pathfinder, etc)
- ERCP in native papilla
- Cholangioscopy
- Therapeutic EUS procedures (FNA/FNB, Stent Placement)
- Planned Mucosal Resection of Polyps \> 20 mm
- Inpatient procedures
- Aborted procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cleveland Clinic Weston
Weston, Florida, 33331, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Director, National Pancreas Center of Excellence, Advanced Therapeutic Endoscopy
Study Record Dates
First Submitted
March 11, 2026
First Posted
March 25, 2026
Study Start
March 10, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
March 25, 2026
Record last verified: 2026-03